 |
|
Tricyclic Antidepressants in Depressed Patients With Cardiac Conduction Disease
Steven P. Roose, MD;
Alexander H. Glassman, MD;
Elsa G. V. Giardina, MD;
B. Timothy Walsh, MD;
Sally Woodring, RN, MA;
J. Thomas Bigger, MD
Arch Gen Psychiatry. 1987;44(3):273-275.
Abstract
• The observation that fatalities from tricyclic antidepressant (TCA) overdose are associated with heart block and/or arrhythmias has led to concern about the cardiovascular effects of TCAs. Contrary to expectations, studies have shown TCAs to be relatively safe in patients without heart disease. However, it is unclear whether these drugs are also safe in patients with heart disease. This prospective study compared the risk of cardiovascular complication at therapeutic plasma concentrations of TCAs in 196 depressed patients, 155 with normal electrocardiograms and 41 with either prolonged PR interval and/or bundle-branch block. The prevalence of second-degree atrioventricular block was significantly greater in patients with preexisting bundle-branch block (9%) than in patients with normal electrocardiograms (0.7%). Orthostatic hypotension occurred significantly more frequently with imipramine than with nortriptyline, and in patients with heart disease.
Author Affiliations
From the Departments of Psychiatry (Drs Roose, Glassman, and Walsh), Medicine (Drs Giardina and Bigger), and Pharmacology (Dr Bigger), College of Physicians and Surgeons, Columbia University, New York; and the New York State Psychiatric Institute, New York (Drs Roose, Glassman, and Walsh and Ms Woodring).
Footnotes
Accepted for publication June 11, 1986.
Reprint requests to New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Roose).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Psychotropic medication and the heart
O'Brien and Oyebode
Adv. Psychiatr. Treat. 2003;9:414-423.
ABSTRACT
| FULL TEXT
Management of Depression in Patients with Comorbid Cardiovascular Disease
Nelson and Abu-Shanab
Journal of Pharmacy Practice 2001;14:526-539.
ABSTRACT
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Roose et al.
JAMA 1998;279:287-291.
ABSTRACT
| FULL TEXT
Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics
Goldstein and Goodnick
J Psychopharmacol 1998;12:55-S87.
ABSTRACT
A Randomized Trial of Nortriptyline for Severe Chronic Tinnitus: Effects on Depression, Disability, and Tinnitus Symptoms
Sullivan et al.
Arch Intern Med 1993;153:2251-2259.
ABSTRACT
Antidepressant therapy in the physically ill: a therapeutic opportunity for the selective 5-HT re-uptake inhibitors?
Lane
J Psychopharmacol 1993;7:112-118.
ABSTRACT
Cyclic Antidepressants and the Risk of Hip Fracture
Ray and Griffin
Arch Intern Med 1991;151:754-756.
ABSTRACT
Syncope and Presyncope Associated With Probable Adverse Drug Reactions
Hanlon et al.
Arch Intern Med 1990;150:2309-2312.
ABSTRACT
Tricyclic Antidepressants in the Intensive Care Unit
Dec and Stern
J Intensive Care Med 1990;5:69-81.
ABSTRACT
Assessment and Treatment of Affective Illness in the Elderly
Jenike
J Geriatr Psychiatry Neurol 1988;1:89-107.
|
